Skip to main content

International Journal of Phytomedicine and Phytotherapy

Table 2 Objective symptom severity at Visit 1 and Visit 2

From: Effectiveness and tolerability of Tonsilgon® N in the treatment of recurrent upper respiratory tract infections in children: a non-interventional study in Russia

   findings [N] visit 2
  visit 1 none mild moderate severe very severe missing
nasopharyngitis hyperemic mucosa none 1 1      
mild 37 36 1     
moderate 203 193 6 1 1   2
severe 97 85 10 1    1
very severe 1 1      
missing        
total 339 316 17 2 1   3
  swollen tonsils none 57 57      
mild 100 98 1     1
moderate 132 128 2 1    1
severe 47 45 1     1
very severe 3 3      
missing        
total 339 331 4 1    3
pharyngitis hyperemic mucosa none        
mild 8 7 1     
moderate 76 68 6 1 1   
severe 62 57 5     
very severe 5 5      
missing        
total 151 137 12 1 1   
  swollen tonsils none 18 18      
mild 39 38 1     
moderate 59 58   1    
severe 31 31      
very severe 4 4      
missing        
total 151 149 1 1    
tonsillitis hyperemic mucosa none        
mild 12 11 1     
moderate 67 59 6 1 1   
severe 25 19 6     
very severe 2 2      
missing        
total 106 91 13 1 1   
swollen tonsils none 1 1      
mild 36 35 1     
moderate 53 51 1 1    
severe 15 15      
very severe 1 1      
missing        
total 106 103 2 1